Prostate-specific antigen is increased in female patients with Cushing's disease

Journal of Endocrinological Investigation

Volumn 25, Issue 9, 2002, Pages RC29-RC31

  Manetti, L ^a   Lupi, I ^a   Bogazzi, F ^a   Pellegrini, G ^b   Precisi, A ^b   Grasso, L ^a   Nencetti, C ^a   Gasperi, M ^a   Martino, Enio ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Cortisol; Cushing; DHEAS; Hyperandrogenism; PSA; T; 4

Indexed keywords

ANDROGEN; BIOCHEMICAL MARKER; PRASTERONE SULFATE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADRENALECTOMY; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CUSHING DISEASE; DISEASE ACTIVITY; DISEASE COURSE; ENZYME BLOOD LEVEL; ENZYME IMMUNOASSAY; FEMALE; HIRSUTISM; HORMONE ACTION; HUMAN; LONGITUDINAL STUDY; NORMAL VALUE; REMISSION; STATISTICAL ANALYSIS; SYMPTOM; TESTOSTERONE BLOOD LEVEL; TRANSSPHENOIDAL SURGERY;

ADOLESCENT; ADULT; CONTROL GROUPS; CUSHING SYNDROME; DEHYDROEPIANDROSTERONE SULFATE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; OSMOLAR CONCENTRATION; PROSTATE-SPECIFIC ANTIGEN; REMISSION INDUCTION; TESTOSTERONE;

EID: 0036797907     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345504     Document Type: Article

References (10)

1. McCormack R.T., Rittenhouse H.G., Finlay J.A., et al.: Molecular forms of prostate specific antigen and the human kallicrein gene family: a new era. Urology. 1995, 45: 729-744.
2. Catalona W.J, Smith D.S., Ratliff T.L., et al.: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N. Engl. J. Med. 1991, 324: 1156-1161.
3. Melegos D.N., Yu H., Ashok M., Wang C., Stanczyk F., Diamandis E.P. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J. Clin. Endocrinol. Metab. 1997, 82: 777-780.
4. Escober-Morreale H.F., Serrano-Gotarredona J., Avila S., Villar-Palasì J., Varela C., Sancho J. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J. Clin. Endocrinol. Metab. 1998, 83: 2580-2581.
5. Negri C., Tosi F., Dorizzi R., et al. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women. J. Clin. Endocrinol. Metab. 2000, 85: 81-84.
6. Obiezu C.V., Scorilas A., Magklara A., et al.: Prostate-specific antigen and human glandular kallikrein 2 are markedly elevated in urine of patients with polycistic ovary syndrome. J. Clin. Endocrinol. Metab. 2001, 86: 1558-1561.
7. Diamandis E.P., Yu H. New biological functions of prostate specific antigen? J. Clin. Endocrinol. Metab. 1995, 80: 1515-1517.
8. Luke M.M., Coffey D.S. Human androgen receptors binding to the androgen response element of prostate specific antigen. J. Androl. 1994, 15: 41-51.
9. Magklara A., Grass L., Diamandis E.P. Differential steroid hormone regulation of human glandular kallikrein (hK2) and prostate-specific antigen (PSA) in breast cancer cell lines. Breast Cancer Res. Treat. 2000, 59: 263-270.
10. Pimentel-Filho F.R., Cukiert A., Miyashita F., et al. Adrenocorticotropin levels do not change during early recovery of transsphenoidal surgery for ACTH-secreting pituitary tumors. J. Endocrinol. Invest. 2001, 24:83-87.